📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias (2022)

First Author: Cantilena S

Attributed to: Molecular mechanisms of eukaryotic ribosome assembly funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ctm2.933

PubMed Identifier: 35730653

Publication URI: http://europepmc.org/abstract/MED/35730653

Type: Journal Article/Review

Parent Publication: Clinical and Translational Medicine

Issue: 6

ISSN: 2001-1326